Information Provided By:
Fly News Breaks for July 1, 2016
PCRX
Jul 1, 2016 | 06:12 EDT
Brean Capital analyst Jonathan Aschoff downgraded Pacira Pharmaceuticals to Hold after the FDA said it is evaluating adverse event reports of local anesthetic systemic toxicity with Exparel. The analyst expects Pacira will face an "increasingly difficult time marketing Exparel."
News For PCRX From the Last 2 Days
There are no results for your query PCRX